| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Atrazine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Herbicide |
| DME Modulation |
Atrazine up-regulates the expression of DME ALDH2 |
[1] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Acrolein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01186
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Acrolein inhibits the drug-metabolizing activity of DME ALDH2 |
[2] |
| N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01385
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide induces the drug-metabolizing activity of DME ALDH2 |
[3] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME ALDH2 |
[4] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Oxadiazon |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01416
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Oxadiazon inhibits the expression of DME ALDH2 |
[5] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Butyraldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Butyraldehyde inhibits the expression of DME ALDH2 |
[6] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Dust |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Dust inhibits the expression of DME ALDH2 |
[7] |
| Particulate matter |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00919
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Particulate matter up-regulates the expression of DME ALDH2 |
[8] |
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution inhibits the expression of DME ALDH2 |
[9] |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Benzaldehydes |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00996
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Benzaldehydes inhibits the drug-metabolizing activity of DME ALDH2 |
[10] |
| Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Plant extracts |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Plant Extract |
| DME Modulation |
Plant extracts induces the drug-metabolizing activity of DME ALDH2 |
[11] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 10 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the expression of DME ALDH2 |
[12] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00018
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclophosphamide up-regulates the expression of DME ALDH2 |
[13] |
| Cyclosporine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine up-regulates the expression of DME ALDH2 |
[14], [15] |
| Dasatinib |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00181
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dasatinib up-regulates the expression of DME ALDH2 |
[16] |
| Decitabine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00168
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Decitabine up-regulates the expression of DME ALDH2 |
[17] |
| Disulfiram |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00028
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Disulfiram inhibits the drug-metabolizing activity of DME ALDH2 |
[10] |
| Hydroquinone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00430
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydroquinone up-regulates the expression of DME ALDH2 |
[18] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00151
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Imatinib mesylate inhibits the expression of DME ALDH2 |
[19] |
| Tretinoin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Tretinoin up-regulates the expression of DME ALDH2 |
[20], [21] |
| Valproic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Valproic acid up-regulates the expression of DME ALDH2 |
[22] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Resveratrol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Resveratrol up-regulates the expression of DME ALDH2 |
[23] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Bisphenol A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A up-regulates the expression of DME ALDH2 |
[24] |
| Ethanol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Ethanol up-regulates the expression of DME ALDH2 |
[25] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Quercetin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin inhibits the drug-metabolizing activity of DME ALDH2 |
[26] |
| Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Sodium arsenite up-regulates the expression of DME ALDH2 |
[27] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| NCS-382 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01393
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
NCS-382 up-regulates the expression of DME ALDH2 |
[28] |
| ICG-001 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 up-regulates the expression of DME ALDH2 |
[29] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 4-hydroxy-2-nonenal |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00869
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME ALDH2 |
[2] |
|
|
|
|
|
|